Belong.Life leverages advanced AI technology to deliver smarter, personalized matches for clinical trials and treatment options. The AI assistant Tara uses machine learning (ML) and natural language processing (NLP) to gather and analyze each patient’s medical information. This enables an ongoing, adaptive search that continuously examines the most relevant clinical trials and therapies, ensuring each patient receives the best possible match for their unique and evolving needs.
Understanding what patients care about, what they do, and what worked for them.
Clinical trials are for patients who have no other options
Clinical trials are a viable treatment option for MS patients since the first diagnosis and allow access to the most advanced therapies and procedures. There are trials for every subtype of MS, including those for symptom management. You should always consider whether there is a better treatment option in clinical trials and discuss it with your doctor.
I will be given a placebo and not the experimental treatment
In most of the MS clinical trials, placebo is rarely given, if it is given, is only for the first year, and thereafter the study drug.
If I was ineligible for one trial, I cannot participate in any trial
Every clinical trial has different inclusion criteria, therefore, being ineligible for one clinical trial would not disqualify a patient from participating in another.
Clinical trials volunteers are regarded as human guinea pigs
There are strict guidelines when conducting a clinical trial, which ensure patients are treated in the best and most ethical way. Most participants say they received great medical attention and care and would recommend other patients to join a trial.
If I have agreed to join a clinical trial, I must see it through.
Clinical trials’ participants are volunteers and therefore, even after signing consent and at any time they wish, they can withdraw from the trial, for any reason.
It’s fast
Trials are matched
to your stage of disease
Local and global
database
Our AI capabilities bridge
the gap of understanding
Remain
anonymous
Your privacy
is safeguarded at all times
It’s fast
Trials are matched
to your stage of disease
Local and global
database
Our AI capabilities bridge
the gap of understanding
Remain
anonymous
Your privacy
is safeguarded at all times
AI clinical trial matching service that gathers patients unique information and find the most personalized relevant clinical trial.
Improved quality of life with multiple sclerosis. The world’s largest social and professional network for MS patients.
Matching Clinical Trials has never been easier for patients
Belong.Life is leading the charge in elevating patient engagement using conversational AI, big data and active patient communities.
Belong’s key solutions include the world’s largest social and professional networks for people living with cancer (Belong – Beating Cancer Together) and multiple sclerosis (BelongMS), and the BelongAI health-grade patient engagement and support platforms (including Dave – Cancer Mentor, Tara for clinical trial matching and more) which utilize AI to proactively support and empower patients throughout their healthcare journey. By enhancing patient education and providing 24/7 support, as well as access to relevant clinical trials, Belong is contributing to improved healthcare outcomes globally.
